Skip to content

An integrated national scale SARS-CoV-2 genomic surveillance network

Research output: Contribution to journalComment/debatepeer-review

The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
Original languageEnglish
Pages (from-to)e99-e100
JournalThe Lancet Microbe
Volume1
Early online date2 Jun 2020
DOIs
Publication statusPublished - 1 Jul 2020

Documents

Related information

Relations Get citation (various referencing formats)

ID: 21216452